|
|
Article: Ingenium and ASINEX Announce Successful Lead Optimization Program.
- Article from:
- PR Newswire
- Article date:
- June 6, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MUNICH and MOSCOW, June 6 /PRNewswire/ -- Ingenium Pharmaceuticals AG, a drug discovery and development company, and ASINEX Ltd., a leading provider of lead generation and chemical optimization services, announced today a successful lead optimization project resulting in the generation of novel active compounds, which will expand Ingenium's current proprietary pipeline of potential treatments for pain and inflammatory diseases. Due to the success of this completed project, the two companies will continue the collaboration throughout 2006.
Commenting on the agreement, Dr. Klaus Dembowsky, Ingenium's Vice President of Drug Discovery, said, "As Ingenium continues to ...
Related newspaper, magazine, and journal articles:
|
|
Article: Ingenium Pharmaceuticals Ag ...
Biomedical Market Newsletter;
September 24, 2003 ;
455 words
...MUNICH GERMANY -- Klaus Dembowsky, M.D., Ph.D., new VP of Drug Discovery, was manager at Bayer in charge of its drug target discovery collaboration with Millennium.
|
|